BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Religare maintains buy on Cadila Healthcare
Despite Cadila's revenue miss in Q1, its operating profit at Rs 530 crore was in-line with estimates. Its EBITDA margin was 50-100 basis points better than estimates. The Moraiya facility resolution is the next stock trigger.